GONAREMON

Serial Number 75659053
606

Registration Progress

Application Filed
Mar 12, 1999
Under Examination
Oct 31, 2000
Approved for Publication
Jul 7, 2000
Published for Opposition
Aug 8, 2000
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: GONAREMON
Previous Owner: Ferring B.V.
Classes: 005

Trademark Image

GONAREMON

Basic Information

Serial Number
75659053
Filing Date
March 12, 1999
Published for Opposition
August 8, 2000
Abandonment Date
October 31, 2002
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 31, 2002
Classes
005

Rights Holder

Ferring B.V.

03
Address
Marsstraat 9
P.O. Box 3129
2130 KC Hoofddorp
NL

Ownership History

Ferring B.V.

Original Applicant
03
2130 KC Hoofddorp NL

Ferring B.V.

Owner at Publication
03
2130 KC Hoofddorp NL

Legal Representation

Attorney
ARNE M. OLSON, Esq

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

15 events
Date Code Type Description Documents
Jun 1, 2003 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 11, 2002 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 8, 2002 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 8, 2002 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 30, 2001 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 8, 2002 MAIL I PAPER RECEIVED Loading...
May 10, 2001 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 27, 2001 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 31, 2000 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 8, 2000 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 7, 2000 NPUB O NOTICE OF PUBLICATION Loading...
Apr 19, 2000 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 22, 2000 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 19, 1999 CNRT F NON-FINAL ACTION MAILED Loading...
Aug 3, 1999 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for use in modulating human fertility and prolonging the survival of the human body suffering from certain onological diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005